IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events

IL12/23 Blockade with Ustekinumab as a Treatment for Immune-Related Cutaneous Adverse Events

<b>Background</b>: Immune-related cutaneous adverse events (ircAEs) are frequent and may reduce quality of life and consistent dosing. IL12/23 has been implicated in psoriasis, which is reminiscent of the psoriasiform/lichenoid ircAE phenotype. We report the use of ustekinumab as a thera...

Full description

Saved in:
Bibliographic Details
Main Authors: Stephanie L. Gu (Author), Tara Maier (Author), Andrea P. Moy (Author), Stephen Dusza (Author), David M. Faleck (Author), Neil J. Shah (Author), Mario E. Lacouture (Author)
Format: Book
Published: MDPI AG, 2023-11-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items